Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Publication Date Organization
Feb
24
2020
 Is “Cannabis User” the Next Protected Class in California? Jackson Lewis P.C.
Feb
24
2020
 340B Ceiling Price Transparency – HRSA Now Requiring Pharmaceutical Manufacturers to Issue Refunds to Covered Entities for Overcharges Mintz
Feb
24
2020
 2019 FDA Precision Medicine Approvals: Progress At FDA Foley & Lardner LLP
Feb
24
2020
 Federal Judge Dismisses Amended Complaint Over Dog Food Labeled as “Natural” Containing Trace Levels of Glyphosate Weed Killer Keller and Heckman LLP
Feb
21
2020
 EPA Releases Proposed Supplemental SNUR on LCPFAC Chemical Substances Bergeson & Campbell, P.C.
Feb
21
2020
 FDA Reopens Comment Period on General Principles for Food Standards Modernization Keller and Heckman LLP
Feb
21
2020
 BRAG Biobased Products Blog: February 21, 2020 Bergeson & Campbell, P.C.
Feb
21
2020
 California Update: New QR Code Certificate Requirements, Uptick in Enforcement Actions, and the Future of California’s Cannabis Regulators Sheppard, Mullin, Richter & Hampton LLP
Feb
21
2020
 EPA Publishes Final List of Low-Priority Chemicals for Risk Evaluation under TSCA Bergeson & Campbell, P.C.
Feb
20
2020
 Alcoholic Cider and Fermented Fruit Beverages – The Conflict Between Federal and Pennsylvania Law Norris McLaughlin P.A.
Feb
20
2020
 JUUL Faces New Lawsuit Over Marketing Tactics Stark & Stark
Feb
19
2020
 U.S. DOT Issues Warning Regarding Use Of CBD Products By DOT-Regulated Employees Jackson Lewis P.C.
Feb
19
2020
 FDA Releases Third and Final Installment of Intentional Adulteration Draft Guidance Keller and Heckman LLP
Feb
18
2020
 Eleventh Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Feb
18
2020
 Top Trends to Look For in Healthcare in 2020 Jackson Lewis P.C.
Feb
18
2020
 Closing the Orphan Drug Act Loophole Mintz
Feb
17
2020
 Ninth Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Feb
17
2020
 Humira: How far can drug makers go to protect their branded market? Wiggin and Dana LLP
Feb
15
2020
 Opioid Update: Sixth Circuit Stays National Dispensing Discovery—For Now Squire Patton Boggs (US) LLP
Feb
14
2020
 Corteva Announces It Will Cease Production of Embattled Insecticide Chlorpyrifos Bergeson & Campbell, P.C.
Feb
14
2020
 Design Patents – Fundamental Additions to Cannabis Intellectual Property Portfolios Brinks Gilson & Lione
Feb
14
2020
 Health Blog: OIG Work Plan Monthly Updates (June-December 2019) von Briesen & Roper, s.c.
Feb
14
2020
 FDA Releases Draft Guidance on Pre-Submission Consultation Process for Animal Food Additive Petitions or Generally Recognized as Safe (GRAS) Notices Keller and Heckman LLP
Feb
13
2020
 Proposed Class Action Lawsuit Claims Arizona Beverage’s Gummies are Not “All Natural” Because They Contain Synthetic Ingredients Keller and Heckman LLP
Feb
13
2020
 Second Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Feb
13
2020
 First Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Feb
13
2020
 NIA Publishes Position Paper on Terminology of “Nanoplastics” Bergeson & Campbell, P.C.
Feb
12
2020
 Analyzing the President’s FY 2021 Budget: Key HHS Proposals McDermott Will & Schulte LLP
Displaying 5965 - 5992 of 12597
Subscribe to The 10 Latest Biological, Life Sciences, and Cleantech Law Articles
 
NLR Logo
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters.

 

Sign Up for any (or all) of our 25+ Newsletters